Results 71 to 80 of about 83,569 (235)
Journal of clinical apheresisExtracorporeal photopheresis (ECP) is widely used for the treatment of cutaneous T‐cell lymphoma, graft‐vs‐host disease, and other immune‐related conditions.
Laura S Connelly-Smith +3 more
semanticscholar +1 more source
A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis. [PDF]
JHLT OpenBackground: Extracorporeal photopheresis (ECP) is considered an emerging rescue therapy for patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to set up a web-based data collection tool for lung transplant patients with ...
Bennett D +11 more
europepmc +2 more sources
Collection efficiency of mononuclear cells in offline extracorporeal photopheresis: can processing time be shortened? [PDF]
Blood Transfus, 2023 Background Extracorporeal photopheresis (ECP) is a well-established but lengthy and burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma, graft-versus-host disease and organ rejection after transplantation.
Kartal O +9 more
europepmc +2 more sources
Transfusion, Volume 65, Issue 5, Page 1007-1011, May 2025.Abstract Background We report a case of suspected Pseudomonas fluorescens transfusion‐transmitted infection in a 64‐year‐old female patient with pancreatic adenocarcinoma. The patient developed a biliary obstruction necessitating a drainage catheter, which was complicated by an arterial hemorrhage.
Nancy El Beayni +4 more
wiley +1 more source
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
Медицинский совет, 2016 Up to 60 thousand hematopoietic stem cell transplantations (HSCT) are carried out globally all over the world. The outcome of HSCT is largely determined by the probability and severity of the graft-versus-host reaction/disease (GVHD).
Y. V. Skvortsova +2 more
doaj +1 more source
Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines
Journal of Clinical Apheresis, Volume 40, Issue 2, April 2025.ABSTRACT Therapeutic plasma exchange (TPE) is widely used in the treatment of autoimmune diseases and hematological emergencies. It is also applied in transplant patients for the desensitization of anti‐HLA (human leukocyte antigen) antibodies and the management of antibody‐mediated rejection.
Davi Mesquita Miranda +3 more
wiley +1 more source
Medicina, 2022 Chronic graft-versus-host disease (cGVHD) is a serious complication after allogenic hematopoietic stem cell transplantation (allo-HSCT), negatively affecting the morbidity and mortality of recipients.
Adrianna Spałek +4 more
doaj +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
British Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis +16 more
wiley +1 more source